Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 2010Antiviral Therapy

The Effect of Efavirenz on the Pharmacokinetics of An Oral Contraceptive Containing Ethinyl Estradiol and Norgestimate in Healthy HIV-Negative Women

View Full Paper
Ask AI
Bookmark
Share

Authors

HSHeather SevinskyBiohaven Pharmaceuticals (United States)TETimothy EleyBristol-Myers Squibb (Germany)APAnna PerssonKarolinska University Hospital

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sevinsky et al. (2010) studied this question.

synapsesocial.com/papers/6aaf67122222a12e8bd06bf3https://doi.org/10.3851/imp1725
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Contraception and HIV infection in women2008 · 52 citations
  2. 2Inhibition of cytochrome P450 2B6 activity by hormone replacement therapy and oral contraceptive as measured by bupropion hydroxylation2003 · 87 citations
  3. 3British HIV Association, BASHH and FSRH guidelines for the management of the sexual and reproductive health of people living with HIV infection 20082008 · 135 citations
  4. 4Induction of Multiple Drug Transporters by Efavirenz2009 · 68 citations
  5. 5Hormonal Contraceptive Use and the Effectiveness of Highly Active Antiretroviral Therapy2005 · 35 citations